The Surprising Path To The Future Of Diagnostic Clinical Trials

In recent years, there has been a significant increase in patient demand for early detection diagnostic modalities within healthcare. At-home tests for allergies, fertility, cholesterol, and more were already becoming popular, but since the advent of the COVID-19 pandemic, sales for diagnostic devices have rapidly increased.¹ And with continued advances in regulation and technology, home diagnostics is moving into other sectors, from diabetes and infectious diseases to heart disease.¹ In-clinic or point-of-care early detection and diagnostic testing for cancer has also skyrocketed.